Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HIV-1-Infection”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT01227824
What this trial is testing

A Trial Comparing GSK1349572 50mg Once Daily to Raltegravir 400mg Twice Daily

Who this might be right for
Infection, Human Immunodeficiency Virus I
ViiV Healthcare 828
Testing effectiveness (Phase 2)Study completedNCT02175680
What this trial is testing

Treatment Substitution With PRO 140 Monotherapy in Adult Subjects With HIV-1 Infection

Who this might be right for
HIVHuman Immunodeficiency Virus
CytoDyn, Inc. 43
Testing effectiveness (Phase 2)Looking for participantsNCT04648046
What this trial is testing

CAR-T Cells for HIV Infection

Who this might be right for
HIV Infections
Steven Deeks 18
Testing effectiveness (Phase 2)UnknownNCT03869944
What this trial is testing

Preventing Childhood HIV: Rescue Intervention. ANRS 12388 PREVENIR-PEV

Who this might be right for
HIV-1
ANRS, Emerging Infectious Diseases 97
Very early researchStudy completedNCT06541093
What this trial is testing

Study to Evaluate the Safety and Immunogenicity of an HIV-1 Vaccine Regimen of Adjuvanted UVAX-1107 Followed by Adjuvanted UVAX-1107 or Adjuvanted UVAX-1197 in Healthy Subjects Aged 25-55 Years.

Who this might be right for
AIDS/HIV - RelatedDisease Associated With AIDSVaccine-Preventable DiseasesHIV Infections
Uvax Bio LLC 34
Large-scale testing (Phase 3)Study completedNCT00146328
What this trial is testing

Rollover Trial Safety and Tolerability of Combination Tipranavir and Ritonavir Use in HIV 1 Infected Subjects

Who this might be right for
HIV Infections
Boehringer Ingelheim 997
Post-approval studies (Phase 4)Ended earlyNCT02322099
What this trial is testing

Alendronate for Prevention of AntiRetroviral Therapy-associated Bone Loss

Who this might be right for
Bone Demineralization
University College Dublin 53
Early research (Phase 1)UnknownNCT03199690
What this trial is testing

A Clinical Study Investigating Rifampicin and Dolutegravir in Combination in Healthy Volunteers

Who this might be right for
HIV-1-infectionTuberculosis
St. Stephens Clinical Research 16
Post-approval studies (Phase 4)Study completedNCT00966329
What this trial is testing

Switching the Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI) or Protease Inhibitor (PI) to Maraviroc in HIV Subjects

Who this might be right for
HIVHIV Infections
Germans Trias i Pujol Hospital 30
Early research (Phase 1)UnknownNCT03980665
What this trial is testing

The Effect of Arsenic Trioxide on Eliminating HIV-1 Reservoir Combined With cART

Who this might be right for
HIV/AIDS
Guangzhou 8th People's Hospital 20
Testing effectiveness (Phase 2)Study completedNCT03639311
What this trial is testing

Phase 2b, Open-label, Multicenter, Rollover Study to Assess Antiviral Activity and Safety of Long-acting (LA) Cabotegravir (CAB) Plus LA Rilpivirine (RPV), Administered Every 2 Months (Q2M), in Human Immunodeficiency Virus (HIV)-Positive Participants From the LATTE Study

Who this might be right for
HIV Infections
ViiV Healthcare 97
Early research (Phase 1)Study completedNCT00001044
What this trial is testing

A Phase I, Multicenter, Randomized, Double-Blind, Placebo-Controlled HIV-1 Vaccine Trial to Evaluate the Safety and Immunogenicity of rgp120/HIV-1MN (Genentech) in Combination With QS21 Adjuvant and/or Alum in Healthy Adults.

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 80
Testing effectiveness (Phase 2)UnknownNCT03536234
What this trial is testing

Efficacy and Safety of GnRH Analogue Triptorelin for HIV-1 Reservoir Reduction in ART Treated HIV-1 Infected Patients

Who this might be right for
HIV-1-infection
Immune System Regulation AB 52
Early research (Phase 1)Study completedNCT00505401
What this trial is testing

Phase I Safety and Immunogenicity Vaccine Trial Against HIV/AIDS

Who this might be right for
HIV Infections
Istituto Superiore di Sanità 27
Early research (Phase 1)Study completedNCT02256631
What this trial is testing

Evaluating the Safety and Pharmacokinetics of VRC01, VRC01LS, and VRC07-523LS, Potent Anti-HIV Neutralizing Monoclonal Antibodies, in HIV-1-Exposed Infants

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 83
Testing effectiveness (Phase 2)Looking for participantsNCT06640192
What this trial is testing

Administration of High Doses of Antiretroviral Drugs to Eliminate the Latent HIV-1 Reservoir

Who this might be right for
HIV-1-infection
Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal 24
Not applicableStudy completedNCT04009057
What this trial is testing

Effectiveness, Safety, Adherence, and Health-related Quality of Life in HIV-1 Infected Adults Receiving Bictegravir/ Emtricitabine/Tenofovir Alafenamide (B/F/TAF)

Who this might be right for
HIV-1-infection
Gilead Sciences 143
Large-scale testing (Phase 3)Study completedNCT00552682
What this trial is testing

Pilot, Opened, Randomized Clinical Trial to Assess the Efficacy of Duloxetine in the Treatment of Fibromialgy in Patients With Infection by HIV 1+

Who this might be right for
FibromyalgiaHIV-1 Infection
Germans Trias i Pujol Hospital 10
Large-scale testing (Phase 3)Looking for participantsNCT07682961
What this trial is testing

Study of Lenacapavir, Teropavimab, and Zinlirvimab Versus Cabotegravir and Rilpivirine in Virologically Suppressed Adults With HIV-1 on Oral Daily Antiretroviral Therapy

Who this might be right for
HIV Infections
Gilead Sciences 590
Early research (Phase 1)Study completedNCT00083603
What this trial is testing

Safety of and Immune Response to Two HIV Vaccine Formulations (rMVA-HIV and rFPV-HIV) Alone or in Combination in HIV Uninfected Adults

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 150
Next Page